Bonaventura J

Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. jbonaventura@ub.edu.

2 papers · ORCID

ArticleKetamine

The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors.

Rizzo A, Garçon-Poca MZ, Essmann A +4

Europe PMC2025
ArticleKetamine

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

Levinstein MR, Budinich RC, Bonaventura J +3

Europe PMC2025